Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Rises By 161.3%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 8,100 shares, a growth of 161.3% from the November 30th total of 3,100 shares. Based on an average daily trading volume, of 6,400 shares, the short-interest ratio is currently 1.3 days.

Lexaria Bioscience Stock Performance

Shares of Lexaria Bioscience stock remained flat at $0.81 on Friday. Lexaria Bioscience has a 12-month low of $0.33 and a 12-month high of $2.50. The stock’s 50 day moving average price is $0.77 and its two-hundred day moving average price is $0.99.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.